Literature DB >> 19181595

Pure red cell aplasia and hypogammaglobulinemia in a patient with thymoma.

Chen-Sung Lin1, Yuan-Bin Yu, Han-Shui Hsu, Teh-Ying Chou, Wen-Hu Hsu, Biing-Shiun Huang.   

Abstract

Both pure red cell aplasia (PRCA) and hypogammaglobulinemia are rarer conditions than myasthenia gravis (MG) in thymoma patients. Several articles have discussed the relation between PRCA and thymoma or hypogammaglobulinemia and thymoma, and their proper treatments. Instances of both PRCA and hypogammaglobulinemia in a thymoma patient are few and reported sporadically in the literature. We discuss a 46-year-old woman with thymoma and simultaneous PRCA and hypogammaglobulinemia who achieved complete remission from PRCA after perioperative steroid administration and extended thymectomy, and review the literature.

Entities:  

Mesh:

Year:  2009        PMID: 19181595     DOI: 10.1016/S1726-4901(09)70017-6

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  4 in total

1.  Thymoma with Concomitant Pure Red Cell Aplasia, Good's Syndrome and Myasthenia Gravis Responding to Rituximab.

Authors:  Ahmad I Antar; Zaher K Otrock; Mohamed A Kharfan-Dabaja; Rami A Mahfouz; Raafat S Alameddine; Nadim M W El-Majzoub; Ziad M Salem
Journal:  Indian J Hematol Blood Transfus       Date:  2014-12-11       Impact factor: 0.900

Review 2.  Good's syndrome remains a mystery after 55 years: A systematic review of the scientific evidence.

Authors:  Theodoros Kelesidis; Otto Yang
Journal:  Clin Immunol       Date:  2010-02-10       Impact factor: 3.969

3.  Thymoma associated with hypogammaglobulinaemia and pure red cell aplasia.

Authors:  Juan Briones; Mirentxu Iruretagoyena; Héctor Galindo; Claudia Ortega; Pablo Zoroquiain; José Valbuena; Francisco Acevedo; Mauricio Ocqueteau; Cesar Sánchez
Journal:  Ecancermedicalscience       Date:  2013-10-17

Review 4.  Characteristics of Good's Syndrome in China: A Systematic Review.

Authors:  Jin-Pei Dong; Wen Gao; Gui-Gen Teng; Yu Tian; Hua-Hong Wang
Journal:  Chin Med J (Engl)       Date:  2017-07-05       Impact factor: 2.628

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.